Characterizing the Degradation of Cannabidiol in an E-liquid Formulation

Overview

Journal Sci Rep

Specialty Science

Date 2022 Nov 22

PMID 36414659

Authors

Adrian Schwarzenberg

Harry Carpenter

Christopher Wright

Omer Bayazeid

Michal Brokl

Affiliations

Soon will be listed here.

Abstract

The reported characteristics of cannabidiol (CBD) have encouraged significant growth in commercial CBD products. There is limited information on the stability of CBD and some researchers have noted significant reductions of CBD in products. In this study, the chemical profiles of plant-based and chemically synthesized CBD in a prototype e-liquid formulation were assessed during 4 weeks of storage under varying conditions. Samples were analysed on days 1, 8, 15, 22, and 29 by untargeted analysis using ultra-high performance liquid chromatography-trapped ion mobility-time-of-flight mass spectrometry (UHPLC-TIMS-TOF-MS). On day 1, analysis of plant-based and synthetic CBD formulations showed small differences in their composition, with plant-based CBD e-liquid containing trace levels of a higher number of phytocannabinoid-related impurities. Storage for 4 weeks under stress (40 °C, 75% relative humidity, dark) and ambient (25 °C, 60% relative humidity, daylight) conditions led to increases in the number and abundance of cannabinoid-related degradation products, including cannabielsoin (CBE) and CBD-hydroxyquinone (HU-331), which are products of the oxidation of CBD, and other unidentified cannabinoid-related compounds. The unidentified cannabinoid-related compounds were probed by accurate mass measurement and MS fragmentation but could not be matched using a mass spectral library derived from 39 commercially available cannabinoid reference standards. Based on elemental composition and MS fragmentation patterns, the unidentified cannabinoid-related compounds were classified as hydroxy-CBE, hydroxy-CBD, and dihydroxy-CBD. The analysis of e-liquid formulations protected from light and stored at 4 °C for 4 weeks indicated only very small increases in CBD oxidation products. The results indicate that CBD degrades in e-liquid solution at ambient temperature in dark and light to form potentially undesirable products, including cannabielsoin and cannabidiol hydroxyquinone.

Citing Articles

Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studies.

Taha I, ElSohly M, Radwan M, Elkanayati R, Wanas A, Joshi P Drug Deliv Transl Res. 2024; .

PMID: 39738884 DOI: 10.1007/s13346-024-01766-9.

A multi-market comparison of composition, formulation, and label content of CBD e-liquids.

Hoeng J, Latino D, Schlage W, Mazurov A, Sherwood N, McKinney W iScience. 2024; 27(11):111154.

PMID: 39524363 PMC: 11550624. DOI: 10.1016/j.isci.2024.111154.

Development and in vitro Evaluation of Cannabidiol Mucoadhesive Buccal Film Formulations Using Hot-Melt Extrusion Technology.

Taha I, ElSohly M, Radwan M, Omari S, Repka M, Ashour E Med Cannabis Cannabinoids. 2024; 7(1):171-182.

PMID: 39474240 PMC: 11521429. DOI: 10.1159/000540353.

A new HPLC method with multiple detection systems for impurity analysis and discrimination of natural versus synthetic cannabidiol.

Brighenti V, Marani M, Caroli C, Bertarini L, Gaggiotti A, Pollastro F Anal Bioanal Chem. 2024; 416(20):4555-4569.

PMID: 38940871 PMC: 11294429. DOI: 10.1007/s00216-024-05396-5.

Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models.

Beben D, Siwiela O, Szyjka A, Graczyk M, Rzepka D, Barg E Curr Issues Mol Biol. 2024; 46(4):3626-3639.

PMID: 38666957 PMC: 11048930. DOI: 10.3390/cimb46040227.

References

Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S . A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ-tetrahydrocannabinol: Δ-Tetrahydrocannabiphorol. Sci Rep. 2020; 9(1):20335. PMC: 6937300. DOI: 10.1038/s41598-019-56785-1. View

Meier F, Beck S, Grassl N, Lubeck M, Park M, Raether O . Parallel Accumulation-Serial Fragmentation (PASEF): Multiplying Sequencing Speed and Sensitivity by Synchronized Scans in a Trapped Ion Mobility Device. J Proteome Res. 2015; 14(12):5378-87. DOI: 10.1021/acs.jproteome.5b00932. View

Vasilopoulou C, Sulek K, Brunner A, Meitei N, Schweiger-Hufnagel U, Meyer S . Trapped ion mobility spectrometry and PASEF enable in-depth lipidomics from minimal sample amounts. Nat Commun. 2020; 11(1):331. PMC: 6965134. DOI: 10.1038/s41467-019-14044-x. View

Schroeder M, Meyer S, Heyman H, Barsch A, Sumner L . Generation of a Collision Cross Section Library for Multi-Dimensional Plant Metabolomics Using UHPLC-Trapped Ion Mobility-MS/MS. Metabolites. 2019; 10(1). PMC: 7023306. DOI: 10.3390/metabo10010013. View

Yamamoto I, Gohda H, Narimatsu S, Watanabe K, Yoshimura H . Cannabielsoin as a new metabolite of cannabidiol in mammals. Pharmacol Biochem Behav. 1991; 40(3):541-6. DOI: 10.1016/0091-3057(91)90360-e. View

Yamamoto I, Gohda H, Narimatsu S, Yoshimura H . Identification of cannabielsoin, a new metabolite of cannabidiol formed by guinea-pig hepatic microsomal enzymes, and its pharmacological activity in mice. J Pharmacobiodyn. 1988; 11(12):833-8. DOI: 10.1248/bpb1978.11.833. View

Giroud C, De Cesare M, Berthet A, Varlet V, Concha-Lozano N, Favrat B . E-Cigarettes: A Review of New Trends in Cannabis Use. Int J Environ Res Public Health. 2015; 12(8):9988-10008. PMC: 4555324. DOI: 10.3390/ijerph120809988. View

Trac J, Keck J, Deweese J . Cannabidiol oxidation product HU-331 is a potential anticancer cannabinoid-quinone: a narrative review. J Cannabis Res. 2021; 3(1):11. PMC: 8067350. DOI: 10.1186/s42238-021-00067-z. View

Mazzetti C, Ferri E, Pozzi M, Labra M . Quantification of the content of cannabinol in commercially available e-liquids and studies on their thermal and photo-stability. Sci Rep. 2020; 10(1):3697. PMC: 7048723. DOI: 10.1038/s41598-020-60477-6. View

10.

Kogan N, Rabinowitz R, Levi P, Gibson D, Sandor P, Schlesinger M . Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. J Med Chem. 2004; 47(15):3800-6. DOI: 10.1021/jm040042o. View

11.

Linciano P, Citti C, Russo F, Tolomeo F, Lagana A, Capriotti A . Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol. Sci Rep. 2020; 10(1):22019. PMC: 7744557. DOI: 10.1038/s41598-020-79042-2. View

12.

Martin B, AGURELL S, Nordqvist M, Lindgren J . Dioxygenated metabolites of cannabidiol formed by rat liver. J Pharm Pharmacol. 1976; 28(8):603-8. DOI: 10.1111/j.2042-7158.1976.tb02809.x. View

13.

Caprioglio D, Mattoteia D, Pollastro F, Negri R, Lopatriello A, Chianese G . The Oxidation of Phytocannabinoids to Cannabinoquinoids. J Nat Prod. 2020; 83(5):1711-1715. PMC: 7997633. DOI: 10.1021/acs.jnatprod.9b01284. View

14.

Meier F, Brunner A, Koch S, Koch H, Lubeck M, Krause M . Online Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer. Mol Cell Proteomics. 2018; 17(12):2534-2545. PMC: 6283298. DOI: 10.1074/mcp.TIR118.000900. View

15.

Citti C, Russo F, Linciano P, Strallhofer S, Tolomeo F, Forni F . Origin of Δ-Tetrahydrocannabinol Impurity in Synthetic Cannabidiol. Cannabis Cannabinoid Res. 2021; 6(1):28-39. PMC: 7891213. DOI: 10.1089/can.2020.0021. View

16.

Kosovic E, Sykora D, Kuchar M . Stability Study of Cannabidiol in the Form of Solid Powder and Sunflower Oil Solution. Pharmaceutics. 2021; 13(3). PMC: 8003596. DOI: 10.3390/pharmaceutics13030412. View

17.

Marinotti O, Sarill M . Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science. J Diet Suppl. 2020; 17(5):517-526. DOI: 10.1080/19390211.2020.1776806. View

18.

Andre C, Hausman J, Guerriero G . Cannabis sativa: The Plant of the Thousand and One Molecules. Front Plant Sci. 2016; 7:19. PMC: 4740396. DOI: 10.3389/fpls.2016.00019. View

19.

Qamar S, Torres Y, Parekh H, Falconer J . Extraction of medicinal cannabinoids through supercritical carbon dioxide technologies: A review. J Chromatogr B Analyt Technol Biomed Life Sci. 2021; 1167:122581. DOI: 10.1016/j.jchromb.2021.122581. View

20.

Fraguas-Sanchez A, Fernandez-Carballido A, Martin-Sabroso C, Torres-Suarez A . Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2020; 1150:122188. DOI: 10.1016/j.jchromb.2020.122188. View